[08.03.2026]
General Catalyst's Chris Bischoff sits down with Forus’s founder and CEO Sahir Jaggi to unpack why one in three patients never get their first dose of prescription medication, how LLMs cut through the complexity stalling the drug supply chain, and how a network built at scale can make scientific progress the only limit on the medicine that people have access to.
[07.10.2026]
Modern Migraine used to leave prior authorizations incomplete because of limited internal capacity. With Forus, the neurology practice can confidently prescribe the therapies their providers choose and help more patients access the care they recommend.
[07.09.2026]
Pairing AGA's clinical leadership with Forus's medication access platform, the strategic partnership aims to help GI patients get faster access to the therapies their physicians prescribe
[07.01.2026]
What providers should know about the Medicare GLP-1 Bridge Program, including patient eligibility, prescribing requirements, and how Forus developed a provider-informed workflow to support prior authorization and pharmacy processing for this new program. Community contributor: Jeffrey H. Schneider, MD, DABOM, dual board-certified in gastroenterology and obesity medicine.
[06.07.2026]
In this Becker's Healthcare Podcast episode, Sahir Jaggi (CEO) discusses how Forus is using AI to automate prior authorizations, appeals, and medication access workflows, helping providers and patients navigate one of healthcare’s most complex challenges.
[06.04.2026]
Forus partnered with Aspire Allergy & Sinus to cut prior authorization turnaround times from two to four weeks to under two days — submitting PAs in under 24 hours, averaging approvals in just 1.7 days, and serving 1,500+ patients across 63 offices in the first few months.
[05.12.2026]
[05.11.2026]
Forus helped one of the country's largest independent allergy practices cut PA turnaround time from 7+ days to 1.1, reduce per-patient workload by 70%, and drive a meaningful lift in first-attempt appeal approvals with data-rich, high-quality letters.
[04.02.2026]
OpenEvidence powers the clinical decision backed by evidence and Forus automates every step from prescription to patient.
[03.02.2026]
MedicoCX, a GPO for independent practices, automates prior auth workflows with Forus and recaptures >75% of staff bandwidth previously spent on manual workflows.
[02.04.2026]
Goodman Dermatology trains the next generation of clinicians while running one of Georgia’s fastest-growing practices. With Forus, patients finally get approval for medications that had stalled at other practices.
[01.21.2026]
An inside look at how Forus' Clinical Intelligence team leverages real-world clinical experience to build products that transform medication access for patients.
